SCHEMBL11223671

SCHEMBL11223671

C[C@H](N[PH](C)=O)C(=O)N1CCC[C@H]1C(=O)[O-].C[C@H](N[PH](C)=O)C(=O)N1CCC[C@H]1C(=O)[O-].[Na+].[Na+]

nearest known ligand 0.47

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 known ✓ O43570 2/20 0.47
▸ CA1 known ✓ P00915 2/20 0.47
▸ CA2 known ✓ P00918 2/20 0.47
▸ ACE known ✓ P12821 8/20 0.40
▸ PTGS1 known ✓ P23219 1/20 0.40
▸ PTGS2 known ✓ P35354 1/20 0.40
▸ CA9 Q16790 2/20 0.47
▸ REN P00797 4/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ F2 P00734 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ LTA4H P09960 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ PEPD P12955 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HRH1 P35367 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11339998 0.86 ACE (0.55) ACERENKDM4EF2LMNA
SCHEMBL11233567 0.80 ACE (0.45) CA12CA1CA2CA9ACE
SCHEMBL11562812 0.74 CA12 (0.49) CA12CA1CA2CA9ACE
Lithium Ion SCHEMBL29774303 0.73 CA12 (0.50) CA12CA1CA2CA9ACE
Potassium Ion SCHEMBL11057114 0.73 DPP4 (0.55) CA12CA1CA2CA9ACE
Potassium Ion SCHEMBL10402342 0.73 CA12 (0.41) CA12CA1CA2CA9ACE
SCHEMBL27905005 0.72 ACE (0.52) CA12CA1CA2CA9ACE
SCHEMBL21022228 0.72 CA12 (0.49) CA12CA1CA2CA9ACE
SCHEMBL19824754 0.72 CA12 (0.49) CA12CA1CA2CA9ACE
SCHEMBL19824776 0.72 CA12 (0.49) CA12CA1CA2CA9ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4316896-A Aminoacid derivatives as antihypertensives MERCK & CO., INC. (US) 1982-02-23 — — US disclosed
EP-0009183-B1 PHOSPHORYL AMINOACID DERIVATIVES AND COMPOSITION FOR TREATING HYPERTENSION CONTAINING THE SAME MERCK & CO. INC. (US) 1981-10-21 — — EP disclosed
EP-0009183-A1 Phosphoryl aminoacid derivatives and composition for treating hypertension containing the same MERCK & CO. INC. (US) 1980-04-02 — — EP disclosed
Send feedback